Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Werewolf Therapeutics (HOWL) Profit After Tax (2021 - 2025)

Werewolf Therapeutics (HOWL) has disclosed Profit After Tax for 5 consecutive years, with -$16.4 million as the latest value for Q3 2025.

  • On a quarterly basis, Profit After Tax rose 1.82% to -$16.4 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$72.8 million, a 17.26% decrease, with the full-year FY2024 number at -$70.5 million, down 88.7% from a year prior.
  • Profit After Tax was -$16.4 million for Q3 2025 at Werewolf Therapeutics, up from -$18.0 million in the prior quarter.
  • In the past five years, Profit After Tax ranged from a high of -$5.1 million in Q2 2023 to a low of -$20.4 million in Q4 2024.
  • A 5-year average of -$13.9 million and a median of -$14.6 million in 2022 define the central range for Profit After Tax.
  • Peak YoY movement for Profit After Tax: soared 65.07% in 2023, then tumbled 238.35% in 2024.
  • Werewolf Therapeutics' Profit After Tax stood at -$17.9 million in 2021, then surged by 33.24% to -$11.9 million in 2022, then fell by 0.61% to -$12.0 million in 2023, then tumbled by 69.96% to -$20.4 million in 2024, then increased by 19.75% to -$16.4 million in 2025.
  • Per Business Quant, the three most recent readings for HOWL's Profit After Tax are -$16.4 million (Q3 2025), -$18.0 million (Q2 2025), and -$18.1 million (Q1 2025).